×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
GRI – gri bio, inc. (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
GRI
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/21
08:49 am
gri
GRI Bio Showcases GRI-0621's Potential to Reduce Inflammation, Type 1 Cytokines and Reduce Hepatic Fibrosis in Idiopathic Pulmonary Fibrosis (IPF) [Yahoo! Finance]
Low
Report
GRI Bio Showcases GRI-0621's Potential to Reduce Inflammation, Type 1 Cytokines and Reduce Hepatic Fibrosis in Idiopathic Pulmonary Fibrosis (IPF) [Yahoo! Finance]
11/21
08:45 am
gri
GRI Bio Showcases GRI-0621’s Potential to Reduce Inflammation, Type 1 Cytokines and Reduce Hepatic Fibrosis in Idiopathic Pulmonary Fibrosis (IPF)
Low
Report
GRI Bio Showcases GRI-0621’s Potential to Reduce Inflammation, Type 1 Cytokines and Reduce Hepatic Fibrosis in Idiopathic Pulmonary Fibrosis (IPF)
11/14
04:20 pm
gri
GRI Bio Reports Third Quarter 2024 Financial Results and Outlines Progress Towards Clinical Data Readout of GRI-0621 in Ongoing Phase 2a Study for Idiopathic Pulmonary Fibrosis
High
Report
GRI Bio Reports Third Quarter 2024 Financial Results and Outlines Progress Towards Clinical Data Readout of GRI-0621 in Ongoing Phase 2a Study for Idiopathic Pulmonary Fibrosis
10/24
08:30 am
gri
GRI Bio Raises a Total of $13.9 Million in Gross Proceeds Since the Beginning of 2024
Medium
Report
GRI Bio Raises a Total of $13.9 Million in Gross Proceeds Since the Beginning of 2024
10/21
05:35 pm
gri
GRI Bio Announces Exercise of Warrants
High
Report
GRI Bio Announces Exercise of Warrants
10/16
11:52 am
gri
GRI Bio Presents Positive Preclinical Data Demonstrating GRI-0621's Ability to Inhibit Invariant Natural Killer T (iNKT) Cell Activity and Reduce Important Inflammatory and Fibrotic Drivers in Idiopathic Pulmonary Fibrosis (IPF) [Yahoo! Finance]
Medium
Report
GRI Bio Presents Positive Preclinical Data Demonstrating GRI-0621's Ability to Inhibit Invariant Natural Killer T (iNKT) Cell Activity and Reduce Important Inflammatory and Fibrotic Drivers in Idiopathic Pulmonary Fibrosis (IPF) [Yahoo! Finance]
10/16
08:45 am
gri
GRI Bio Presents Positive Preclinical Data Demonstrating GRI-0621’s Ability to Inhibit Invariant Natural Killer T (iNKT) Cell Activity and Reduce Important Inflammatory and Fibrotic Drivers in Idiopathic Pulmonary Fibrosis (IPF)
High
Report
GRI Bio Presents Positive Preclinical Data Demonstrating GRI-0621’s Ability to Inhibit Invariant Natural Killer T (iNKT) Cell Activity and Reduce Important Inflammatory and Fibrotic Drivers in Idiopathic Pulmonary Fibrosis (IPF)
10/8
08:45 am
gri
GRI Bio, Inc. (NASDAQ: GRI) is now covered by analysts at Ascendiant Capital Markets. They set a "buy" rating and a $12.00 price target on the stock.
Medium
Report
GRI Bio, Inc. (NASDAQ: GRI) is now covered by analysts at Ascendiant Capital Markets. They set a "buy" rating and a $12.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
11/14
04:25 pm
gri
Form 8-K GRI Bio, Inc. For: Nov 14
High
Report
Form 8-K GRI Bio, Inc. For: Nov 14
11/14
04:18 pm
gri
Form 10-Q GRI Bio, Inc. For: Sep 30
High
Report
Form 10-Q GRI Bio, Inc. For: Sep 30
10/24
08:36 am
gri
Form 8-K GRI BIO, Inc. For: Oct 24
Low
Report
Form 8-K GRI BIO, Inc. For: Oct 24
10/22
04:22 pm
gri
Form 8-K GRI BIO, Inc. For: Oct 21
High
Report
Form 8-K GRI BIO, Inc. For: Oct 21
9/11
04:37 pm
gri
Form 8-K/A GRI BIO, Inc. For: Sep 10
Medium
Report
Form 8-K/A GRI BIO, Inc. For: Sep 10
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: